Rituximab-Induced Hypogammaglobulinemia in Multiple Sclerosis
Clinical trial NCT04283747 · UNKNOWN
Trial details
- NCT number
- NCT04283747
- Sponsor
- Mazandaran University of Medical Sciences
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2020-02-28
- Primary completion
- 2022-10-01
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.